Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,474 | 1,476 | 860 | 1,022 | 956 |
| Income taxes - deferred | -282 | 275 | -926 | 0 | 69 |
| Accounts receivable | 2,389 | -1,662 | -3,128 | -1,409 | 705 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 3,241 | 1,201 |
| Other Working Capital | -1,383 | 141 | -2,078 | 541 | 676 |
| Other Operating Activity | -2,252 | 2,806 | 4,087 | -4,187 | -3,023 |
| Operating Cash Flow | $-54 | $3,036 | $-1,185 | $-792 | $583 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | -17 | -23 | -10 | -11 |
| Net Acquisitions | -502 | N/A | -27,935 | 0 | N/A |
| Purchase Sale Intangibles | 0 | 0 | 66 | 0 | -361 |
| Other Investing Activity | 1 | 1 | 10 | 53 | 66 |
| Investing Cash Flow | $-552 | $-15 | $-27,882 | $43 | $-307 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 899 | N/A | 18,897 | 0 | N/A |
| Debt Repayment | -87 | -158 | -85 | -88 | -72 |
| Common Stock Repurchased | 0 | 0 | -168 | -1,111 | -842 |
| Other Financing Activity | -1,357 | -671 | -343 | -11 | -966 |
| Financing Cash Flow | $-545 | $-830 | $18,301 | $-1,210 | $-1,879 |
| Exchange Rate Effect | -81 | -144 | 456 | -160 | 79 |
| Beginning Cash Position | 7,636 | 5,436 | 17,308 | 19,427 | 20,693 |
| End Cash Position | 6,403 | 7,484 | 5,235 | 17,308 | 19,170 |
| Net Cash Flow | $-1,151 | $2,191 | $-10,765 | $-1,959 | $-1,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54 | 3,036 | -1,185 | -792 | 583 |
| Capital Expenditure | -51 | -17 | N/A | -10 | -372 |
| Free Cash Flow | -105 | 3,019 | -1,185 | -802 | 211 |